NEW YORK, Feb 19 (Reuters) - Generic drugmaker Actavis Plc has begun discussions with its core bank group to syndicate the $7 billion financing slated to back its acquisition of Forest Laboratories Inc, sources told Thomson Reuters LPC.
Read more here >>
Reuters |
Quails
